SLI
2.105,17
PKT
-35,84
PKT
-1,67
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 29.11.06 | UBS equal-weight | Morgan Stanley | |
| 29.11.06 | UBS overweight | Morgan Stanley | |
| 29.11.06 | Novartis buy | Bank Sarasin & Cie | |
| 01.12.06 | Richemont halten | Hamburger Sparkasse | |
| 30.11.06 | Novartis kaufen | Helaba Trust | |
| 30.11.06 | Novartis equal-weight | Morgan Stanley | |
| 28.11.06 | Zurich Insurance overweight | JP Morgan | |
| 28.11.06 | UBS overweight | JP Morgan | |
| 27.11.06 | Holcim | Wirtschaftswoche | |
| 24.11.06 | Zurich Insurance | DZ-Bank | |
| 24.11.06 | Novartis | DZ-Bank | |
| 24.11.06 | Nestlé | DZ-Bank | |
| 23.11.06 | Givaudan outperform | HypoVereinsbank | |
| 22.11.06 | Holcim buy | Banque SYZ & CO | |
| 21.11.06 | Adecco SA halten | Hamburger Sparkasse | |
| 21.11.06 | Adecco SA overweight | Morgan Stanley | |
| 20.11.06 | Zurich Insurance overweight | JP Morgan | |
| 17.11.06 | Novartis equal-weight | Morgan Stanley | |
| 17.11.06 | Swiss Life hold | Citigroup | |
| 17.11.06 | Zurich Insurance | DZ-Bank | |
| 17.11.06 | Novartis | DZ-Bank | |
| 17.11.06 | Nestlé | DZ-Bank | |
| 16.11.06 | Swiss Life kaufen | M.M. Warburg | |
| 16.11.06 | Swiss Life neutral | JP Morgan | |
| 15.11.06 | Swiss Life halten | Nord LB | |
| 15.11.06 | Swiss Life outperform | HypoVereinsbank | |
| 14.11.06 | Novartis buy | Bank Sarasin & Cie | |
| 14.11.06 | Novartis neutral | JP Morgan | |
| 14.11.06 | Swiss Life Outperformer | LB Rheinland-Pfalz | |
| 15.11.06 | Novartis buy | SEB | |
| 13.11.06 | UBS | Wirtschaftswoche | |
| 14.11.06 | Novartis buy | Merrill Lynch | |
| 10.11.06 | UBS halten | Hamburger Sparkasse | |
| 10.11.06 | Zurich Insurance | DZ-Bank | |
| 10.11.06 | Novartis | DZ-Bank | |
| 10.11.06 | Nestlé | DZ-Bank | |
| 13.11.06 | Richemont buy | Bank Sarasin & Cie | |
| 09.11.06 | Holcim verkaufen | Helaba Trust | |
| 10.11.06 | Swiss Life outperform | HypoVereinsbank | |
| 09.11.06 | Holcim kaufen | Helaba Trust |